Sponsors

Company Profile

Nature Technology Corporation

Vaccines
Biopharmaceuticals
Other
Viral vectors, DNA manufacturing, DNA vaccines

4701 Innovation Dr.
Lincoln, NE 68521
USA
www.natx.com 		Incorporated in 1988
8 Employees 		Privately Held

This Year's Highlights

  • World record reported yields of plasmid DNA from fermentation, 1.6g/L
  • $980,000 Phase II SBIR award from NIH-NIGMS for strain and process development pursuant to DNA plasmid manufacturing
  • Autolytic strains of bacteria capable of removing impurities during plasmid DNA purification.

Anticipated Highlights

  • Technology transfer of HyperGRO process to NIH Vaccine Research Center
  • Completion of anthrax vaccine preclinical studies with Navy
  • Completion of rapid vaccine development and deployment system

Corporate Mission

NTC?s mission is to provide improved platform technologies and services for nucleic acid-based products, adding value from serial use in multiple products. NTC's innovator technologies include superior platforms and compositions for manufacturing for next-genertion DNA vaccines and gene-based pharmaecuticals. NTC's goals are, to secure its development status and partner with customers in the implementation of technologies, particularly with regard to vaccines.